Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Safety and Efficacy of Riliprubart, an Activated C1s-complement Inhibitor in CIDP: 76-week Phase Two Trial Results

Author:Querol, Luis   Lewis, Richard A.   Hartung, Hans-Peter   van Doorn, Pieter A.   Lin, Jie   Dionne, Annie   Attarian, Shahram   Wallstroem, Erik   Auwarter, Kristen   Lu, Yi   Alonso-Alonso, Miguel   Atassi, Nazem   Hughes, Richard A. C.   

Session Name:S2: Updates on Motor Neuron and Peripheral Nerve Disorders  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S2.008  

Author Institution:Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain  Centro para la Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Madrid, Spain, Spain  Department of Neurology, Cedars Sinai Medical Center, Los Angeles, CA, USA, CA  Department of Neurology, Faculty of Medicine, Heinrich-Heine-University, Düsseldorf, Germany  Brain and Mind Center, University of Sydney, Sydney, NSW, Australia  Department of Neurology, Medical University of Vienna, Vienna, Austria  Department of Neurology, Palacky University Olomouc, Olomouc, The Czech Republic, Dusseldorf, Germany  Erasmus MC, University Medical Center, Rotterdam, The Netherlands, Netherlands  Department of Neurology and Rare Disease Center, Huashan Hospital, Fudan University, Shanghai, China, Shanghai, China, People's Republic of  CHU de Quebec Universite Laval, Quebec, Canada, QC, Canada  Neuromuscular Disease and ALS Reference Center, Timone University Hospital, Aix-Marseille University, CHU Timone, Marseille Cedex 05, France, France  Sanofi R&D, Neurology Development, Cambridge, MA, USA, Cambridge, MA  Sanofi, USA, MA  Sanofi R&D, Biostatistics and Programming, Cambridge, MA, USA, CA  Sanofi R&D, Neurology Development, Cambridge, MA, USA, MA  UCL Queen Square Institute of Neurology, University College London, London, UK, United Kingdom  

Machine Learning Tools to Predict Subclinical Small-vessel Brain Lesions Using AHA Life’s Essential 8: Evidence from the ELSA-Brasil Longitudinal Study

Author:Leite, Marianna   Savalli, Carine   B. Oliveira, Arão   Leandro, Carlos   A. Lotufo, Paulo   Benseñor, Isabela   C Leite, Claudia   CG Otaduy, Maria   de Souza Santos, Itamar   B Conforto, Adriana   C Goulart, Alessandra   Chiavegatto, Alexandre   

Session Name:S4: Hot Topics in Global Health and Neuroepidemiology  

Topic:Global Health and Neuroepidemiology  

Program Number:S4.005  

Author Institution:School of Public Health, Department of Epidemiology, University of São Paulo, São Paulo, Brazil. Santa Marcelina School of Medicine, São Paulo, Brazil, São Paulo, Brazil  Federal University of São Paulo, Department of Public Policies and Collective Health, São Paulo, Brazil, Brazil  Center for Clinical and Epidemiological Research, Hospital Universitario, University of Sao Paulo, Brazil. School of Public Health, Department of Epidemiology, University of São Paulo, São Paulo, Brazil, Brazil  LIM-44, Instituto e Departamento de Radiologia e Oncologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil, Brazil  Center for Clinical and Epidemiological Research, Hospital Universitario, University of Sao Paulo, Brazil. School of Medicine, Universidade de São Paulo, São Paulo, Brazil, Brazil  School of Public Health, Department of Epidemiology, University of São Paulo, São Paulo, Brazil. Center for Clinical and Epidemiological Research, Hospital Universitario, University of Sao Paulo, Brazil, Brazil  School of Public Health, Department of Epidemiology, University of São Paulo, São Paulo, Brazil, Brazil  

Functional Outcomes of Refractory Status Epilepticus and Super-refractory Status Epilepticus in Specific Etiologies

Phase II/III Study of Ulviprubart in Inclusion Body Myositis: Study Design, Patient Characteristics, and Topline Results

Author:Goyal, Namita A.   Machado, Pedro M.   Ascherman, Dana P.   Benveniste, Olivier   Beydoun, Said R.   Brannagan, Thomas H.   Christopher-Stine, Lisa   Collins, Michael P.   De Bleecker, Jan L.   Dimachkie, Mazen   Dixon, Stacy   Fernandez, David R.   Freimer, Miriam   Geiger, Christopher   Gonzalez-Perez, Paloma   Goyal, Neelam   Gwathmey, Kelly   Heitzman, Daragh   Henderson, Robert D.   Hodson-Webb, Lisa D.   Hussain, Yessar   Korngut, Lawrence   Liang, Christina   Lilleker, James B.   Lloyd, Thomas   Mohassel, Payam   Naddaf, Elie   Needham, Merrilee   Piccione, Ezequiel   Quinn, Colin C.   Rosow, Laura   Roy, Bhaskar   Ruck, Tobias   Schmidt, Jens   Seth, Arjun   Shah, Jaimin   Shaibani, Aziz   Shieh, Perry B.   Simmons, Zachary   Sivakumar, Kumaraswamy   Wang, Leo H.   Weihl, Conrad C.   Wilkins, H. Jeffrey   Amato, Anthony   

Session Name:S7: Updates on Muscle Disorders  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S7.007  

Author Institution:Department of Neurology, University of California Irvine, Orange, CA, USA, Orange, CA  Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK  NIHR University College London Hospitals Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK, London, United Kingdom  Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA, Pittsburgh, PA  Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière University Hospital, Sorbonne Université, AP-HP, Paris, France, Paris, France  University of Southern California, Los Angeles, CA, USA, Los Angeles, CA  Neurological Institute, Columbia University Medical Center, New York, NY, USA, New York, NY  Johns Hopkins University School of Medicine, Baltimore, MD, USA, Baltimore, MD  Medical College of Wisconsin, Milwaukee, WI, USA, Milwaukee, WI  Department of Neurology and Neuromuscular Reference Center, Ghent University Hospital, Ghent, Belgium, Ghent, Belgium  Department of Neurology, The University of Kansas Medical Center, Kansas City, KS, USA, Kansas City, KS  University of Colorado, Aurora, CO, USA, Aurora, CO  Department of Rheumatology, Hospital for Special Surgery, New York, NY, USA, New York, NY  Department of Neurology, The Ohio State Wexner Medical Center, Columbus, OH, USA, Columbus, OH  University Hospitals-Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA, Cleveland, OH  Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA, Boston, MA  Stanford Neuroscience Health Center, Palo Alto, CA, USA, Palo Alto, CA  Department of Neurology, Virginia Commonwealth University, Richmond, VA, USA, Henrico, VA  Texas Neurology, Dallas, TX, USA, Dallas, TX  Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Australia  Centre for Clinical Research, University of Queensland, Brisbane, Australia, Brisbane, Australia  Neuromuscular Division/Department of Neurology, Duke University, Durham, NC, USA, Durham, NC  Austin Neuromuscular Center, Austin, TX, USA, Austin, TX  Hotchkiss Brain Institute, Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Alberta, Canada, Calgary, AB, Canada  Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia  Department of Neurology, Royal North Shore Hospital, Northern Sydney Local Health District, Sydney, New South Wales Australia  Neuroscience Research Australia, Sydney, New South Wales, Australia, Australia  Manchester Centre for Clinical Neurosciences, Northern Care Alliance NHS Foundation Trust, Salford, UK  The University of Manchester, Manchester, UK, United Kingdom  Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA  Department of Neurology, Baylor College of Medicine, Houston, TX, USA  Department of Clinical Research, Imricor Medical Systems, Burnsville, MN, USA, Houston, TX  Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA, Baltimore, MD  Department of Neurology, Mayo Clinic, Rochester, MN, USA, Rochester, MN  Perron Institute, QEII Medical Centre, Nedlands, Western Australia, Australia  University of Notre Dame, Perth, Western Australia, Australia  Fiona Stanley Hospital, Perth, Western Australia, Australia  Murdoch University, Perth, Western Australia, Australia, Murdoch, Australia  Department of Neurology, University of Nebraska Medical Center, Omaha, NE, USA, Omaha, NE  Neuromuscular Division, Neurology Department, University of Pennsylvania, Philadelphia, PA, USA, PA  University of California San Francisco, San Francisco, CA, USA, San Francisco, CA  Department of Neurology, Yale School of Medicine, New Haven, CT, USA, New Haven, CT  Ruhr University Bochum, BG-University Hospital Bergmannsheil Department of Neurology, Bochum, Germany  Heimer Institute for Muscle Research, BG-University Hospital Bergmannsheil Department of Neurology, Bochum, Germany, Düsseldorf, Germany  Department of Neurology, Neuromuscular Center, University Medical Center Göttingen, Göttingen, Germany  Department of Neurology and Pain Treatment, Neuromuscular Center, Center for Translational Medicine, Immanuel University Hospital, Brandenburg Medical School, Rüdersdorf bei Berlin, Germany, Rüdersdorf bei Berlin, Germany  Department of Neurology, Northwestern Memorial Hospital, Chicago, IL, USA, Chicago, IL  Department of Neurology, Mayo Clinic, Jacksonville, FL, USA, Jacksonville, FL  Nerve and Muscle Center of Texas, Houston, TX, USA, Houston, TX  Department of Pediatrics, University of California Los Angeles, Los Angeles, CA, USA, Los Angeles, CA  Department of Neurology, Penn State University College of Medicine, Hershey, PA, USA, Hershey, PA  The Neuromuscular Research Centre and Neuromuscular Clinic of Arizona, Phoenix, AZ, USA, Paradise Valley, AZ  Department of Neurology, University of Washington, Seattle, WA, USA, WA  Department of Neurology, Washington University in St Louis, St Louis, MO, USA, MO  Abcuro, Inc., Newton, MA, USA, MA  Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA, Boston, MA